1-4 of 4
Veronique Edeline, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study

Olivier Casasnovas, MD, Judith Racape, MD, Julie Dechene, Reda Bouabdallah, MD, Pauline Brice, MD, Julien Lazarovici, MD, Hervé Ghesquieres, MD PhD, Aspasia Stamatoulas Bastard, MD, Jehan Dupuis, MD, Anne-Claire Gac, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Pierre Feugier, MD, Franck Morschhauser, MD PhD, Marc André, MD, Alina Berriolo-Riedinger, MD, Veronique Edeline, MD, Clémentine Joubert, PhD, Michel Meignan, MD, Isabelle Demeestere, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136056
Published: 2020
Journal Articles

Brentuximab Vedotin in First Refractory/Relapsed Classical Hodgkin Lymphoma Patients Treated By Chemotherapy (ICE) before Autologous Transplantation. Final Analysis of Phase II Study

Aspasia Stamatoullas, MD, Herv Ghesquieres, Lauriane Clement filliatre, MD, Philippe Quittet, MD, Franck Morschhauser, MD, Vincent Ribrag, MD, Veronique Edeline, MD, Pauline Brice
Journal: Blood
Blood (2019) 134 (Supplement_1): 132.
https://doi.org/10.1182/blood-2019-123925
Published: 2019
Journal Articles

The Combination of High Expression of CD68-Positive Tumor-Associated Macrophages and PET2-Positivity Predicts Unfavorable Outcome in Patients with Classical Hodgkin Lymphoma Treated in the Lysa AHL2011 Study

Alexandra Traverse-Glehen, MD PhD, Diane Damotte, MD PhD, Peggy Dartigues, MD, Laurent Martin, MD PhD, Marie Parrens, MD PhD, Hervé Guesquieres, Clementine Sarkozy, Bénédicte Deau, MD, Reda Bouabdallah, MD, Sylvain Garciaz, MD, Michel Meignan, MD PhD, Véronique Edeline, MD, Salim Kanoun, MD, Alina Berriolo-Riedinger, MD, Pauline Brice, MD, Cedric Rossi, MD, Aspasia Stamatoullas, MD, Anne Sophie Veillard, Marc Andre, MD, Olivier Casasnovas, MD
Journal: Blood
Blood (2016) 128 (22): 1825.
https://doi.org/10.1182/blood.V128.22.1825.1825
Published: 2016
Journal Articles

Randomized Phase III Study Comparing an Early PET Driven Treatment De-Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study

Olivier Casasnovas, MD, Pauline Brice, MD, Reda Bouabdallah, MD, Gilles A. Salles, MD PhD, Aspasia Stamatoullas, MD, Jehan Dupuis, MD, Oumedaly Reman, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Serge Bologna, MD, Franck Morschhauser, MD, Richard Delarue, MD, Hassan Farhat, MD, Philippe Quittet, MD, Alina Berriolo-Riedinger, MD, Adrian Tempescul, Véronique Edeline, MD, Herve Maisonneuve, MD, Jean Claude Eisenmann, MD, Alexandra Traverse-Glehen, Marc Andre, MD, Nicolas Mounier, MD PhD, Michel Meignan, MD PhD, Christophe Fermé, MD
Journal: Blood
Blood (2015) 126 (23): 577.
https://doi.org/10.1182/blood.V126.23.577.577
Published: 2015